< 0 1 0 1 O
3 2 3 2 3 B-upper_bound
times 4 9 4 9 I-upper_bound
upper 10 15 10 15 I-upper_bound
limit 16 21 16 21 I-upper_bound
of 22 24 22 24 I-upper_bound
normal 25 31 25 31 I-upper_bound
( 32 33 32 33 I-upper_bound
ULN 33 36 33 36 I-upper_bound
) 36 37 36 37 I-upper_bound

> 0 1 38 39 O
12.5 2 6 40 44 B-lower_bound
mg 7 9 45 47 I-lower_bound
/ 9 10 47 48 I-lower_bound
dl 10 12 48 50 I-lower_bound
( 13 14 51 52 O
> 14 15 52 53 O
3.1 16 19 54 57 B-lower_bound
mmol 20 24 58 62 I-lower_bound
/ 24 25 62 63 I-lower_bound
L 25 26 63 64 I-lower_bound
) 26 27 64 65 O
despite 28 35 66 73 O
intervention 36 48 74 86 O
to 49 51 87 89 O
normalize 52 61 90 99 O
levels 62 68 100 106 O

> 0 1 107 108 O
3 2 3 109 110 B-lower_bound
mg 4 6 111 113 I-lower_bound
/ 6 7 113 114 I-lower_bound
dl 7 9 114 116 I-lower_bound
( 10 11 117 118 O
> 11 12 118 119 O
1.23 13 17 120 124 B-lower_bound
mmol 18 22 125 129 I-lower_bound
/ 22 23 129 130 I-lower_bound
L 23 24 130 131 I-lower_bound
) 24 25 131 132 O
despite 26 33 133 140 O
intervention 34 46 141 153 O
to 47 49 154 156 O
normalize 50 59 157 166 O
levels 60 66 167 173 O

> 0 1 174 175 O
6 2 3 176 177 B-lower_bound
mmol 4 8 178 182 I-lower_bound
/ 8 9 182 183 I-lower_bound
L 9 10 183 184 I-lower_bound
despite 11 18 185 192 O
intervention 19 31 193 205 O
to 32 34 206 208 O
normalize 35 44 209 218 O
levels 45 51 219 225 O

AST 0 3 226 229 B-clinical_variable
( 4 5 230 231 I-clinical_variable
aspartate 5 14 231 240 I-clinical_variable
aminotransferase 15 31 241 257 I-clinical_variable
) 31 32 257 258 I-clinical_variable
and 33 36 259 262 O
ALT 37 40 263 266 B-clinical_variable
( 41 42 267 268 I-clinical_variable
alanine 42 49 268 275 I-clinical_variable
aminotransferase 50 66 276 292 I-clinical_variable
) 66 67 292 293 I-clinical_variable

Absolute 0 8 294 302 B-clinical_variable
neutrophil 9 19 303 313 I-clinical_variable
count 20 25 314 319 I-clinical_variable
( 26 27 320 321 I-clinical_variable
ANC 27 30 321 324 I-clinical_variable
) 30 31 324 325 I-clinical_variable
> 32 33 326 327 O
1500 34 38 328 332 B-lower_bound
/ 38 39 332 333 I-lower_bound
mm3 39 42 333 336 I-lower_bound

Age 0 3 337 340 B-age
≥ 4 5 341 342 O
18 6 8 343 345 B-lower_bound

All 0 3 346 349 B-gender
females 4 11 350 357 I-gender
of 12 14 358 360 O
childbearing 15 27 361 373 O
potential 28 37 374 383 O
must 38 42 384 388 O
have 43 47 389 393 O
a 48 49 394 395 O
blood 50 55 396 401 O
test 56 60 402 406 O
or 61 63 407 409 O
urine 64 69 410 415 O
study 70 75 416 421 O

Appropriate 0 11 422 433 O
studies 12 19 434 441 O
will 20 24 442 446 O
be 25 27 447 449 O
undertaken 28 38 450 460 O
in 39 41 461 463 O
patients 42 50 464 472 O
receiving 51 60 473 482 O
combination 61 72 483 494 O
anti 73 77 495 499 B-treatment
- 77 78 499 500 I-treatment
retroviral 78 88 500 510 I-treatment
therapy 89 96 511 518 I-treatment
when 97 101 519 523 O
indicated 102 111 524 533 O

Biopsy 0 6 534 540 B-treatment
sampling 7 15 541 549 O
of 16 18 550 552 O
primary 19 26 553 560 B-cancer
tumor 27 32 561 566 I-cancer
with 33 37 567 571 O
pathology 38 47 572 581 O
report 48 54 582 588 O
documenting 55 66 589 600 O
diagnostic 67 77 601 611 O
tissue 78 84 612 618 O
type 85 89 619 623 O
is 90 92 624 626 O
required 93 101 627 635 O

Calculated 0 10 636 646 B-clinical_variable
Creatinine 11 21 647 657 I-clinical_variable
Clearance 22 31 658 667 I-clinical_variable
= 32 33 668 669 O
[ 34 35 670 671 O
( 35 36 671 672 O
140 36 39 672 675 O
- 39 40 675 676 O
age 40 43 676 679 B-age
) 43 44 679 680 O
X 45 46 681 682 O
( 47 48 683 684 O
actual 48 54 684 690 O
body 55 59 691 695 O
weight 60 66 696 702 O
in 67 69 703 705 O
kg 70 72 706 708 O
) 72 73 708 709 O
X 74 75 710 711 O
( 76 77 712 713 O
0.85 77 81 713 717 O
if 82 84 718 720 O
female)]/(72 85 97 721 733 B-gender
X 98 99 734 735 O
serum 100 105 736 741 B-clinical_variable
creatinine 106 116 742 752 I-clinical_variable
) 116 117 752 753 O

Creatinine 0 10 754 764 B-clinical_variable
clearance 11 20 765 774 I-clinical_variable
≥ 21 22 775 776 O
45 23 25 777 779 B-lower_bound
ml 26 28 780 782 I-lower_bound
/ 28 29 782 783 I-lower_bound
min 29 32 783 786 I-lower_bound
determined 33 43 787 797 O
by 44 46 798 800 O
24 47 49 801 803 O
- 49 50 803 804 O
hour 50 54 804 808 O
collection 55 65 809 819 O

Diagnostic 0 10 820 830 O
biopsy 11 17 831 837 B-treatment
of 18 20 838 840 O
primary 21 28 841 848 B-cancer
tumor 29 34 849 854 I-cancer
and/or 35 41 855 861 O
nodal 42 47 862 867 O
sites 48 53 868 873 O
is 54 56 874 876 O
permitted 57 66 877 886 O

Diagnostic 0 10 887 897 O
primary 11 18 898 905 B-cancer
tumor 19 24 906 911 I-cancer
tissue 25 31 912 918 I-cancer
must 32 36 919 923 O
be 37 39 924 926 O
available 40 49 927 936 O
for 50 53 937 940 O
ERCC1 54 59 941 946 B-treatment
staining 60 68 947 955 I-treatment

Diagnostic 0 10 956 966 O
simple 11 17 967 973 O
tonsillectomy 18 31 974 987 B-treatment
is 32 34 988 990 O
permitted 35 44 991 1000 O
, 44 45 1000 1001 O
provided 46 54 1002 1010 O
patient 55 62 1011 1018 O
has 63 66 1019 1022 O
RECIST 67 73 1023 1029 O
- 73 74 1029 1030 O
measurable 74 84 1030 1040 O
residual 85 93 1041 1049 O
tumor 94 99 1050 1055 B-cancer
and/or 100 106 1056 1062 O
nodal 107 112 1063 1068 B-cancer
disease 113 120 1069 1076 I-cancer

Eastern 0 7 1077 1084 B-clinical_variable
Cooperative 8 19 1085 1096 I-clinical_variable
Oncology 20 28 1097 1105 I-clinical_variable
Group 29 34 1106 1111 I-clinical_variable
( 35 36 1112 1113 I-clinical_variable
ECOG 36 40 1113 1117 I-clinical_variable
) 40 41 1117 1118 I-clinical_variable
Performance 42 53 1119 1130 I-clinical_variable
Status 54 60 1131 1137 I-clinical_variable
0 61 62 1138 1139 B-lower_bound
- 62 63 1139 1140 O
1 63 64 1140 1141 B-upper_bound
( 65 66 1142 1143 O
See 66 69 1143 1146 O
Appendix 70 78 1147 1155 O
8) 79 81 1156 1158 O

HIV 0 3 1159 1162 B-chronic_disease
testing 4 11 1163 1170 O
is 12 14 1171 1173 O
not 15 18 1174 1177 O
required 19 27 1178 1186 O
for 28 31 1187 1190 O
entry 32 37 1191 1196 O
into 38 42 1197 1201 O
this 43 47 1202 1206 O
protocol 48 56 1207 1215 O

HIV 0 3 1216 1219 B-chronic_disease
- 3 4 1219 1220 O
positive 4 12 1220 1228 O
patients 13 21 1229 1237 O
receiving 22 31 1238 1247 O
combination 32 43 1248 1259 O
anti 44 48 1260 1264 B-treatment
- 48 49 1264 1265 I-treatment
retroviral 49 59 1265 1275 I-treatment
therapy 60 67 1276 1283 I-treatment
are 68 71 1284 1287 O
excluded 72 80 1288 1296 O
from 81 85 1297 1301 O
the 86 89 1302 1305 O
study 90 95 1306 1311 O
because 96 103 1312 1319 O
of 104 106 1320 1322 O
possible 107 115 1323 1331 O
drug 116 120 1332 1336 O
interactions 121 133 1337 1349 O
with 134 138 1350 1354 O
study 139 144 1355 1360 B-treatment
drugs 145 150 1361 1366 I-treatment

Hemoglobin 0 10 1367 1377 B-clinical_variable
( 11 12 1378 1379 I-clinical_variable
Hb 12 14 1379 1381 I-clinical_variable
) 14 15 1381 1382 I-clinical_variable
> 16 17 1383 1384 O
8.0 18 21 1385 1388 B-lower_bound
g 22 23 1389 1390 I-lower_bound
/ 23 24 1390 1391 I-lower_bound
dL 24 26 1391 1393 I-lower_bound

Informed 0 8 1394 1402 O
consent 9 16 1403 1410 O
must 17 21 1411 1415 O
be 22 24 1416 1418 O
obtained 25 33 1419 1427 O
from 34 38 1428 1432 O
all 39 42 1433 1436 O
patients 43 51 1437 1445 O
prior 52 57 1446 1451 O
to 58 60 1452 1454 O
beginning 61 70 1455 1464 O
therapy 71 78 1465 1472 B-treatment
, 78 79 1472 1473 O
including 80 89 1474 1483 O
consent 90 97 1484 1491 O
for 98 101 1492 1495 O
mandatory 102 111 1496 1505 O
tissue 112 118 1506 1512 O
submission 119 129 1513 1523 O
for 130 133 1524 1527 O
ERCC1 134 139 1528 1533 B-clinical_variable
staining 140 148 1534 1542 O
( 149 150 1543 1544 O
and 150 153 1544 1547 O
p16 154 157 1548 1551 B-clinical_variable
staining 158 166 1552 1560 O
if 167 169 1561 1563 O
not 170 173 1564 1567 O
locally 174 181 1568 1575 O
conducted 182 191 1576 1585 O
) 191 192 1585 1586 O

Magnesium 0 9 1587 1596 B-clinical_variable
< 10 11 1597 1598 O
0.9 12 15 1599 1602 B-upper_bound
mg 16 18 1603 1605 I-upper_bound
/ 18 19 1605 1606 I-upper_bound
dl 19 21 1606 1608 I-upper_bound
( 22 23 1609 1610 O
< 23 24 1610 1611 O
0.4 25 28 1612 1615 B-upper_bound
mmol 29 33 1616 1620 I-upper_bound
/ 33 34 1620 1621 I-upper_bound
L 34 35 1621 1622 I-upper_bound
) 35 36 1622 1623 O

No 0 2 1624 1626 O
prior 3 8 1627 1632 O
severe 9 15 1633 1639 O
infusion 16 24 1640 1648 O
reaction 25 33 1649 1657 O
to 34 36 1658 1660 O
a 37 38 1661 1662 O
monoclonal 39 49 1663 1673 B-treatment
antibody 50 58 1674 1682 I-treatment

No 0 2 1683 1685 O
prior 3 8 1686 1691 B-treatment
systemic 9 17 1692 1700 I-treatment
treatment 18 27 1701 1710 I-treatment
( 28 29 1711 1712 O
chemotherapy 29 41 1712 1724 B-treatment
or 42 44 1725 1727 O
biologic 45 53 1728 1736 B-treatment
/ 53 54 1736 1737 O
molecular 54 63 1737 1746 B-treatment
targeted 64 72 1747 1755 I-treatment
therapy 73 80 1756 1763 I-treatment
) 80 81 1763 1764 O

No 0 2 1765 1767 O
uncontrolled 3 15 1768 1780 O
intercurrent 16 28 1781 1793 O
illness 29 36 1794 1801 O
including 37 46 1802 1811 O
active 47 53 1812 1818 B-chronic_disease
infection 54 63 1819 1828 I-chronic_disease
, 63 64 1828 1829 O
uncontrolled 65 77 1830 1842 B-chronic_disease
diabetes 78 86 1843 1851 I-chronic_disease
, 86 87 1851 1852 O
uncontrolled 88 100 1853 1865 B-chronic_disease
hypertension 101 113 1866 1878 I-chronic_disease

No 0 2 1879 1881 O
unstable 3 11 1882 1890 B-chronic_disease
angina 12 18 1891 1897 I-chronic_disease
or 19 21 1898 1900 O
myocardial 22 32 1901 1911 B-chronic_disease
infarction 33 43 1912 1922 I-chronic_disease
within 44 50 1923 1929 O
the 51 54 1930 1933 O
prior 55 60 1934 1939 B-upper_bound
6 61 62 1940 1941 I-upper_bound
months 63 69 1942 1948 I-upper_bound

Pathologically 0 14 1949 1963 O
confirmed 15 24 1964 1973 O
squamous 25 33 1974 1982 B-cancer
cell 34 38 1983 1987 I-cancer
carcinoma 39 48 1988 1997 I-cancer
, 48 49 1997 1998 O
undifferentiated 50 66 1999 2015 O
carcinoma 67 76 2016 2025 O

Patients 0 8 2026 2034 O
may 9 12 2035 2038 O
have 13 17 2039 2043 O
received 18 26 2044 2052 O
chemotherapy 27 39 2053 2065 B-treatment
or 40 42 2066 2068 O
radiation 43 52 2069 2078 B-treatment
for 53 56 2079 2082 O
a 57 58 2083 2084 O
previous 59 67 2085 2093 O
, 67 68 2093 2094 O
curatively 69 79 2095 2105 O
treated 80 87 2106 2113 O
non 88 91 2114 2117 B-cancer
- 91 92 2117 2118 I-cancer
HNSCC 92 97 2118 2123 I-cancer
malignancy 98 108 2124 2134 I-cancer

Patients 0 8 2135 2143 O
may 9 12 2144 2147 O
not 13 16 2148 2151 O
be 17 19 2152 2154 O
receiving 20 29 2155 2164 O
any 30 33 2165 2168 O
other 34 39 2169 2174 O
anti 40 44 2175 2179 O
- 44 45 2179 2180 O
neoplastic 45 55 2180 2190 O
investigational 56 71 2191 2206 B-treatment
agents 72 78 2207 2213 I-treatment

Patients 0 8 2214 2222 O
must 9 13 2223 2227 O
be 14 16 2228 2230 O
untreated 17 26 2231 2240 O
with 27 31 2241 2245 O
curative 32 40 2246 2254 O
- 40 41 2254 2255 O
intent 41 47 2255 2261 O
surgery 48 55 2262 2269 B-treatment
for 56 59 2270 2273 O
current 60 67 2274 2281 O
diagnosis 68 77 2282 2291 O
of 78 80 2292 2294 O
Stage 81 86 2295 2300 B-lower_bound
III 87 90 2301 2304 I-lower_bound
, 90 91 2304 2305 O
IVa 92 95 2306 2309 O
, 95 96 2309 2310 O
or 97 99 2311 2313 O
IVb 100 103 2314 2317 B-upper_bound
disease 104 111 2318 2325 B-chronic_disease

Patients 0 8 2326 2334 O
must 9 13 2335 2339 O
be 14 16 2340 2342 O
untreated 17 26 2343 2352 O
with 27 31 2353 2357 O
radiation 32 41 2358 2367 B-treatment
above 42 47 2368 2373 O
the 48 51 2374 2377 O
clavicles 52 61 2378 2387 O

Patients 0 8 2388 2396 O
must 9 13 2397 2401 O
have 14 18 2402 2406 O
measurable 19 29 2407 2417 B-chronic_disease
disease 30 37 2418 2425 I-chronic_disease
according 38 47 2426 2435 O
to 48 50 2436 2438 O
RECIST 51 57 2439 2445 O
1.1 58 61 2446 2449 O

Patients 0 8 2450 2458 O
must 9 13 2459 2463 O
have 14 18 2464 2468 O
the 19 22 2469 2472 O
following 23 32 2473 2482 O
laboratory 33 43 2483 2493 O
values 44 50 2494 2500 O
measured 51 59 2501 2509 O
within 60 66 2510 2516 O
14 67 69 2517 2519 B-upper_bound
days 70 74 2520 2524 I-upper_bound
of 75 77 2525 2527 O
registration 78 90 2528 2540 O

Patients 0 8 2541 2549 O
with 9 13 2550 2554 O
a 14 15 2555 2556 O
history 16 23 2557 2564 O
of 24 26 2565 2567 O
curatively 27 37 2568 2578 O
- 37 38 2578 2579 O
treated 38 45 2579 2586 O
non 46 49 2587 2590 B-cancer
- 49 50 2590 2591 I-cancer
HNSCC 50 55 2591 2596 I-cancer
malignancy 56 66 2597 2607 I-cancer

Patients 0 8 2608 2616 O
with 9 13 2617 2621 O
a 14 15 2622 2623 O
second 16 22 2624 2630 O
HNSCC 23 28 2631 2636 B-cancer
primary 29 36 2637 2644 B-cancer
tumor 37 42 2645 2650 I-cancer
are 43 46 2651 2654 O
eligible 47 55 2655 2663 O
for 56 59 2664 2667 O
this 60 64 2668 2672 O
study 65 70 2673 2678 O
, 70 71 2678 2679 O
provided 72 80 2680 2688 O
more 81 85 2689 2693 O
than 86 90 2694 2698 O
2 91 92 2699 2700 B-lower_bound
years 93 98 2701 2706 I-lower_bound
have 99 103 2707 2711 O
elapsed 104 111 2712 2719 O
since 112 117 2720 2725 O
the 118 121 2726 2729 O
first 122 127 2730 2735 O
diagnosis 128 137 2736 2745 O
of 138 140 2746 2748 O
HNSCC 141 146 2749 2754 O
, 146 147 2754 2755 O
the 148 151 2756 2759 O
original 152 160 2760 2768 O
tumor 161 166 2769 2774 O
was 167 170 2775 2778 O
managed 171 178 2779 2786 O
with 179 183 2787 2791 O
surgery 184 191 2792 2799 B-treatment
only 192 196 2800 2804 O
( 197 198 2805 2806 O
no 198 200 2806 2808 O
adjuvant 201 209 2809 2817 O
chemotherapy 210 222 2818 2830 I-treatment
/ 222 223 2830 2831 O
radiotherapy 223 235 2831 2843 B-treatment
) 235 236 2843 2844 O
, 236 237 2844 2845 O
and 238 241 2846 2849 O
has 242 245 2850 2853 O
not 246 249 2854 2857 O
recurred 250 258 2858 2866 O

Patients 0 8 2867 2875 O
with 9 13 2876 2880 O
an 14 16 2881 2883 O
initial 17 24 2884 2891 B-clinical_variable
magnesium 25 34 2892 2901 I-clinical_variable
< 35 36 2902 2903 O
0.5 37 40 2904 2907 B-upper_bound
mmol 41 45 2908 2912 I-upper_bound
/ 45 46 2912 2913 I-upper_bound
L 46 47 2913 2914 I-upper_bound
( 48 49 2915 2916 I-upper_bound
1.2 49 52 2916 2919 I-upper_bound
mg 53 55 2920 2922 I-upper_bound
/ 55 56 2922 2923 I-upper_bound
dl 56 58 2923 2925 I-upper_bound
) 58 59 2925 2926 I-upper_bound

Patients 0 8 2927 2935 O
with 9 13 2936 2940 O
oropharyngeal 14 27 2941 2954 B-cancer
squamous 28 36 2955 2963 I-cancer
cell 37 41 2964 2968 I-cancer
carcinoma 42 51 2969 2978 I-cancer
may 52 55 2979 2982 O
have 56 60 2983 2987 O
p16(+ 61 66 2988 2993 B-cancer
) 66 67 2993 2994 I-cancer
or 68 70 2995 2997 I-cancer
p16(- 71 76 2998 3003 I-cancer
) 76 77 3003 3004 I-cancer
disease 78 85 3005 3012 I-cancer

Patients 0 8 3013 3021 O
with 9 13 3022 3026 O
simultaneous 14 26 3027 3039 O
primaries 27 36 3040 3049 O
or 37 39 3050 3052 O
bilateral 40 49 3053 3062 B-cancer
tumors 50 56 3063 3069 I-cancer
are 57 60 3070 3073 O
excluded 61 69 3074 3082 O

Platelet 0 8 3083 3091 B-clinical_variable
count 9 14 3092 3097 I-clinical_variable
( 15 16 3098 3099 I-clinical_variable
PLT 16 19 3099 3102 I-clinical_variable
) 19 20 3102 3103 I-clinical_variable
> 21 22 3104 3105 O
100,000 23 30 3106 3113 B-lower_bound
/ 30 31 3113 3114 I-lower_bound
mm3 31 34 3114 3117 I-lower_bound

Potassium 0 9 3118 3127 B-clinical_variable
< 10 11 3128 3129 O
3.5 12 15 3130 3133 B-upper_bound
mmol 16 20 3134 3138 I-upper_bound
/ 20 21 3138 3139 I-upper_bound
L 21 22 3139 3140 I-upper_bound

Pregnant 0 8 3141 3149 B-pregnancy
women 9 14 3150 3155 B-gender
are 15 18 3156 3159 O
excluded 19 27 3160 3168 O
from 28 32 3169 3173 O
this 33 37 3174 3178 O
study 38 43 3179 3184 O
because 44 51 3185 3192 O
chemotherapy 52 64 3193 3205 B-treatment

Serum 0 5 3206 3211 B-clinical_variable
bilirubin 6 15 3212 3221 I-clinical_variable
< 16 17 3222 3223 O
2 18 19 3224 3225 B-upper_bound
mg 20 22 3226 3228 I-upper_bound
/ 22 23 3228 3229 I-upper_bound
dL 23 25 3229 3231 I-upper_bound

Serum 0 5 3232 3237 B-clinical_variable
calcium 6 13 3238 3245 I-clinical_variable
( 14 15 3246 3247 O
ionized 15 22 3247 3254 O
or 23 25 3255 3257 O
adjusted 26 34 3258 3266 O
for 35 38 3267 3270 O
albumin 39 46 3271 3278 O
) 46 47 3278 3279 O
< 48 49 3280 3281 O
7 50 51 3282 3283 B-upper_bound
mg 52 54 3284 3286 I-upper_bound
/ 54 55 3286 3287 I-upper_bound
dl 55 57 3287 3289 I-upper_bound
( 58 59 3290 3291 I-upper_bound
1.75 59 63 3291 3295 I-upper_bound
mmol 64 68 3296 3300 I-upper_bound
/ 68 69 3300 3301 I-upper_bound
L 69 70 3301 3302 I-upper_bound
) 70 71 3302 3303 I-upper_bound

Should 0 6 3304 3310 O
a 7 8 3311 3312 O
woman 9 14 3313 3318 B-gender
become 15 21 3319 3325 B-pregnancy
pregnant 22 30 3326 3334 I-pregnancy
or 31 33 3335 3337 O
suspect 34 41 3338 3345 O
she 42 45 3346 3349 O
is 46 48 3350 3352 O
pregnant 49 57 3353 3361 O
while 58 63 3362 3367 O
in 64 66 3368 3370 O
this 67 71 3371 3375 O
study 72 77 3376 3381 O
, 77 78 3381 3382 O
she 79 82 3383 3386 O
should 83 89 3387 3393 O
inform 90 96 3394 3400 O
her 97 100 3401 3404 O
treating 101 109 3405 3413 O
physician 110 119 3414 3423 O
immediately 120 131 3424 3435 O

Sodium 0 6 3436 3442 B-clinical_variable
< 7 8 3443 3444 O
130 9 12 3445 3448 B-upper_bound
mmol 13 17 3449 3453 I-upper_bound
/ 17 18 3453 3454 I-upper_bound
L 18 19 3454 3455 I-upper_bound
or 20 22 3456 3458 O
> 23 24 3459 3460 O
155 25 28 3461 3464 B-lower_bound
mmol 29 33 3465 3469 I-lower_bound
/ 33 34 3469 3470 I-lower_bound
L 34 35 3470 3471 I-lower_bound
despite 36 43 3472 3479 O
intervention 44 56 3480 3492 O
to 57 59 3493 3495 O
normalize 60 69 3496 3505 O
levels 70 76 3506 3512 O

The 0 3 3513 3516 O
definition 4 14 3517 3527 O
of 15 17 3528 3530 O
p16(+ 18 23 3531 3536 B-chronic_disease
) 23 24 3536 3537 I-chronic_disease
disease 25 32 3538 3545 I-chronic_disease
is 33 35 3546 3548 O
diffuse 36 43 3549 3556 O
nuclear 44 51 3557 3564 O
and 52 55 3565 3568 O
cytoplasmic 56 67 3569 3580 B-clinical_variable
staining 68 76 3581 3589 I-clinical_variable
in 77 79 3590 3592 O
≥ 80 81 3593 3594 O
70 82 84 3595 3597 B-lower_bound
% 84 85 3597 3598 I-lower_bound
of 86 88 3599 3601 O
tumor 89 94 3602 3607 B-cancer
cells 95 100 3608 3613 O

The 0 3 3614 3617 O
following 4 13 3618 3627 O
assessments 14 25 3628 3639 O
are 26 29 3640 3643 O
required 30 38 3644 3652 O
within 39 45 3653 3659 O
14 46 48 3660 3662 B-upper_bound
days 49 53 3663 3667 I-upper_bound
prior 54 59 3668 3673 I-upper_bound
to 60 62 3674 3676 O
registration 63 75 3677 3689 O

Women 0 5 3690 3695 B-gender
must 6 10 3696 3700 O
not 11 14 3701 3704 B-pregnancy
be 15 17 3705 3707 I-pregnancy
pregnant 18 26 3708 3716 I-pregnancy

Women 0 5 3717 3722 B-gender
of 6 8 3723 3725 O
child 9 14 3726 3731 O
- 14 15 3731 3732 O
bearing 15 22 3732 3739 O
potential 23 32 3740 3749 O

Written 0 7 3750 3757 O
informed 8 16 3758 3766 O
consent 17 24 3767 3774 O
must 25 29 3775 3779 O
be 30 32 3780 3782 O
obtained 33 41 3783 3791 O
from 42 46 3792 3796 O
all 47 50 3797 3800 O
patients 51 59 3801 3809 O
prior 60 65 3810 3815 O
to 66 68 3816 3818 O
beginning 69 78 3819 3828 O
therapy 79 86 3829 3836 B-treatment

breast 0 6 3837 3843 O
feeding 7 14 3844 3851 O
because 15 22 3852 3859 O
chemotherapy 23 35 3860 3872 B-treatment

cetuximab 0 9 3873 3882 B-treatment
have 10 14 3883 3887 O
the 15 18 3888 3891 O
potential 19 28 3892 3901 O
for 29 32 3902 3905 O
teratogenic 33 44 3906 3917 B-treatment
or 45 47 3918 3920 O
abortifacient 48 61 3921 3934 O
effect 62 68 3935 3941 O

cetuximab 0 9 3942 3951 B-treatment
may 10 13 3952 3955 O
be 14 16 3956 3958 O
harmful 17 24 3959 3966 O
to 25 27 3967 3969 O
the 28 31 3970 3973 O
fetus 32 37 3974 3979 O
or 38 40 3980 3982 O
the 41 44 3983 3986 O
nursing 45 52 3987 3994 O
infant 53 59 3995 4001 O

estimated 0 9 4002 4011 O
by 10 12 4012 4014 O
the 13 16 4015 4018 O
Cockraft 17 25 4019 4027 B-clinical_variable
- 25 26 4027 4028 I-clinical_variable
Gault 26 31 4028 4033 I-clinical_variable
formula 32 39 4034 4041 I-clinical_variable

hypopharynx 0 11 4042 4053 O
with 12 16 4054 4058 O
no 17 19 4059 4061 O
evidence 20 28 4062 4070 O
of 29 31 4071 4073 O
distant 32 39 4074 4081 B-cancer
metastasis 40 50 4082 4092 I-cancer

may 0 3 4093 4096 O
receive 4 11 4097 4104 O
corrective 12 22 4105 4115 B-treatment
magnesium 23 32 4116 4125 I-treatment
supplementation 33 48 4126 4141 I-treatment
but 49 52 4142 4145 O
should 53 59 4146 4152 O
continue 60 68 4153 4161 O
to 69 71 4162 4164 O
receive 72 79 4165 4172 O
either 80 86 4173 4179 O
prophylactic 87 99 4180 4192 B-treatment
weekly 100 106 4193 4199 O
infusion 107 115 4200 4208 B-treatment
of 116 118 4209 4211 I-treatment
magnesium 119 128 4212 4221 I-treatment
and/or 129 135 4222 4228 O
oral 136 140 4229 4233 B-treatment
magnesium 141 150 4234 4243 I-treatment
supplementation 151 166 4244 4259 I-treatment
( 167 168 4260 4261 O
eg 168 170 4261 4263 O
, 170 171 4263 4264 O
magnesium 172 181 4265 4274 B-treatment
oxide 182 187 4275 4280 I-treatment
) 187 188 4280 4281 O
at 189 191 4282 4284 O
the 192 195 4285 4288 O
investigator 196 208 4289 4301 O
's 208 210 4301 4303 O
discretion 211 221 4304 4314 O

men 0 3 4315 4318 B-gender
must 4 8 4319 4323 O
agree 9 14 4324 4329 B-contraception_consent
to 15 17 4330 4332 I-contraception_consent
use 18 21 4333 4336 I-contraception_consent
adequate 22 30 4337 4345 I-contraception_consent
contraception 31 44 4346 4359 I-contraception_consent
( 45 46 4360 4361 O
hormonal 46 54 4361 4369 B-contraception_consent
or 55 57 4370 4372 O
barrier 58 65 4373 4380 B-contraception_consent
method 66 72 4381 4387 I-contraception_consent
of 73 75 4388 4390 I-contraception_consent
birth 76 81 4391 4396 I-contraception_consent
control 82 89 4397 4404 I-contraception_consent
) 89 90 4404 4405 O
prior 91 96 4406 4411 O
to 97 99 4412 4414 O
study 100 105 4415 4420 O
entry 106 111 4421 4426 O
and 112 115 4427 4430 O
for 116 119 4431 4434 O
the 120 123 4435 4438 O
duration 124 132 4439 4447 O
of 133 135 4448 4450 O
study 136 141 4451 4456 O
participation 142 155 4457 4470 O

must 0 4 4471 4475 O
be 5 7 4476 4478 O
disease 8 15 4479 4486 O
- 15 16 4486 4487 O
free 16 20 4487 4491 O
for 21 24 4492 4495 O
at 25 27 4496 4498 O
least 28 33 4499 4504 O
2 34 35 4505 4506 B-lower_bound
years 36 41 4507 4512 I-lower_bound
except 42 48 4513 4519 O
for 49 52 4520 4523 O
carcinoma 53 62 4524 4533 B-cancer
- 62 63 4533 4534 I-cancer
in 63 65 4534 4536 I-cancer
- 65 66 4536 4537 I-cancer
situ 66 70 4537 4541 I-cancer
of 71 73 4542 4544 O
cervix 74 80 4545 4551 O

no 0 2 4552 4554 O
cerebrovascular 3 18 4555 4570 B-chronic_disease
ischemia 19 27 4571 4579 I-chronic_disease
or 28 30 4580 4582 O
stroke 31 37 4583 4589 B-chronic_disease
within 38 44 4590 4596 O
the 45 48 4597 4600 O
past 49 53 4601 4605 B-upper_bound
6 54 55 4606 4607 I-upper_bound
months 56 62 4608 4614 I-upper_bound

no 0 2 4615 4617 O
serious 3 10 4618 4625 O
cardiac 11 18 4626 4633 B-chronic_disease
arrhythmia 19 29 4634 4644 I-chronic_disease
requiring 30 39 4645 4654 O
medication 40 50 4655 4665 B-treatment

no 0 2 4666 4668 O
symptomatic 3 14 4669 4680 O
congestive 15 25 4681 4691 B-chronic_disease
heart 26 31 4692 4697 I-chronic_disease
failure 32 39 4698 4705 I-chronic_disease

non 0 3 4706 4709 B-cancer
- 3 4 4709 4710 I-cancer
melanomatous 4 16 4710 4722 I-cancer
skin 17 21 4723 4727 I-cancer
cancer 22 28 4728 4734 I-cancer
, 28 29 4734 4735 O
or 30 32 4736 4738 O
T1 33 35 4739 4741 B-lower_bound
- 35 36 4741 4742 O
2 36 37 4742 4743 B-upper_bound
, 37 38 4743 4744 O
N0 39 41 4745 4747 O
, 41 42 4747 4748 O
M0 43 45 4749 4751 O
resected 46 54 4752 4760 O
differentiated 55 69 4761 4775 O
thyroid 70 77 4776 4783 B-cancer
carcinoma 78 87 4784 4793 I-cancer

p16 0 3 4794 4797 B-cancer
status 4 10 4798 4804 I-cancer
must 11 15 4805 4809 O
be 16 18 4810 4812 O
known 19 24 4813 4818 O
prior 25 30 4819 4824 O
to 31 33 4825 4827 O
randomization 34 47 4828 4841 O

patients 0 8 4842 4850 O
with 9 13 4851 4855 O
T1 14 16 4856 4858 B-cancer
- 16 17 4858 4859 I-cancer
2 17 18 4859 4860 I-cancer
, 18 19 4860 4861 O
N0 20 22 4862 4864 B-cancer
, 22 23 4864 4865 O
M0 24 26 4866 4868 B-cancer
resected 27 35 4869 4877 O
differentiated 36 50 4878 4892 O
thyroid 51 58 4893 4900 B-cancer
carcinoma 59 68 4901 4910 I-cancer
, 68 69 4910 4911 O
who 70 73 4912 4915 O
are 74 77 4916 4919 O
eligible 78 86 4920 4928 O

poorly 0 6 4929 4935 O
differentiated 7 21 4936 4950 O
carcinoma 22 31 4951 4960 B-cancer
of 32 34 4961 4963 O
the 35 38 4964 4967 O
oropharynx 39 49 4968 4978 O
, 49 50 4978 4979 O
larynx 51 57 4980 4986 O

provided 0 8 4987 4995 O
at 9 11 4996 4998 O
least 12 17 4999 5004 O
2 18 19 5005 5006 B-lower_bound
years 20 25 5007 5012 I-lower_bound
have 26 30 5013 5017 O
elapsed 31 38 5018 5025 O

radiation 0 9 5026 5035 B-treatment
treatment 10 19 5036 5045 I-treatment
for 20 23 5046 5049 O
head 24 28 5050 5054 B-cancer
and 29 32 5055 5058 I-cancer
neck 33 37 5059 5063 I-cancer
cancer 38 44 5064 5070 I-cancer

uncontrolled 0 12 5071 5083 O
psychiatric 13 24 5084 5095 B-chronic_disease
illness 25 32 5096 5103 I-chronic_disease
which 33 38 5104 5109 O
in 39 41 5110 5112 O
the 42 45 5113 5116 O
investigator 46 58 5117 5129 O
's 58 60 5129 5131 O
opinion 61 68 5132 5139 O
would 69 74 5140 5145 O
limit 75 80 5146 5151 O
compliance 81 91 5152 5162 O
with 92 96 5163 5167 O
study 97 102 5168 5173 O
requirements 103 115 5174 5186 O
or 116 118 5187 5189 O
compromise 119 129 5190 5200 O
patient 130 137 5201 5208 O
safety 138 144 5209 5215 O

with 0 4 5216 5220 O
the 5 8 5221 5224 O
exception 9 18 5225 5234 O
of 19 21 5235 5237 O
patients 22 30 5238 5246 O
with 31 35 5247 5251 O
bilateral 36 45 5252 5261 B-cancer
tonsil 46 52 5262 5268 I-cancer
cancers 53 60 5269 5276 I-cancer

within 0 6 5277 5283 O
14 7 9 5284 5286 B-upper_bound
days 10 14 5287 5291 I-upper_bound
of 15 17 5292 5294 O
registration 18 30 5295 5307 O
to 31 33 5308 5310 O
rule 34 38 5311 5315 O
out 39 42 5316 5319 O
pregnancy 43 52 5320 5329 B-pregnancy

